Alpha Biopharma

Alpha Biopharma is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, with an additional office in Beijing. The company focuses on the clinical development and commercialization of global innovative drugs across oncology and immunotherapy, spanning medical affairs, clinical operations, regulatory affairs and commercialization. Its lead product is Zorifertinib (formerly AZD-3759, marketed as Zorifer), a next-generation EGFR TKI designed for EGFR mutation positive advanced NSCLC patients with central nervous system metastases, which received NMPA approval in November 2024 as the first EGFR-TKI indicated for lung cancer with brain metastases. Alpha Biopharma also partners with Wugen Inc. on universal off-the-shelf memory NK and CAR-T cell therapies. The company raised a Series A led by Qiming Venture Partners. Alpha Biopharma publishes a corporate marketing website only and operates no public API, developer portal, or software platform.

Alpha Biopharma is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Pharmaceuticals, Oncology, and Immunotherapy.

Alpha Biopharma’s developer surface includes engineering blog and 16 more developer resources.

🌐 Visit website 📡 Source on GitHub

4.5/100 minimal ▬ flat Agent 0/100 human only library Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0

0 APIs

Company Biopharmaceutical Pharmaceuticals Oncology Immunotherapy Clinical Development Life Sciences China

Kin Score

Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0

Composite quality — 4.5/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/alphabiopharma: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Alphabiopharma Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Agent Surfaces 2

MCP servers, agent skills, and machine-readable catalogs

WellKnown

WellKnown

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

Packages

Packages

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Company 6

The organization behind the API

Website

About

Blog

Press

Careers

Investors

Other 6

Properties that don't map to a standard resource type

Pipeline

Publications

Research

Products

TherapeuticAreas

CorporateSocialResponsibility

CorporateSocialResponsibility

Source (apis.yml)

aid: alphabiopharma
deliveryModel:
  model: library
  open_source: false
  commercial: false
  callable_host: false
  label: Library · distributed through package registries, no callable service
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alphabiopharma.png
name: Alpha Biopharma
description: Alpha Biopharma is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in Shanghai,
  China, with an additional office in Beijing. The company focuses on the clinical development and commercialization of global
  innovative drugs across oncology and immunotherapy, spanning medical affairs, clinical operations, regulatory affairs and
  commercialization. Its lead product is Zorifertinib (formerly AZD-3759, marketed as Zorifer), a next-generation EGFR TKI
  designed for EGFR mutation positive advanced NSCLC patients with central nervous system metastases, which received NMPA
  approval in November 2024 as the first EGFR-TKI indicated for lung cancer with brain metastases. Alpha Biopharma also partners
  with Wugen Inc. on universal off-the-shelf memory NK and CAR-T cell therapies. The company raised a Series A led by Qiming
  Venture Partners. Alpha Biopharma publishes a corporate marketing website only and operates no public API, developer portal,
  or software platform.
url: https://raw.githubusercontent.com/api-evangelist/alphabiopharma/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: no-public-api-surface
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biopharmaceutical
- Pharmaceuticals
- Oncology
- Immunotherapy
- Clinical Development
- Life Sciences
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/alphabiopharma-domain-security.yml
- type: Website
  url: https://www.alphabiopharma.com/en/
- type: About
  url: https://www.alphabiopharma.com/en/company/1.html
- type: Blog
  url: https://www.alphabiopharma.com/en/news/15.html
- type: Press
  url: https://www.alphabiopharma.com/en/news/36.html
- type: Pipeline
  url: https://www.alphabiopharma.com/en/productline/30.html
- type: Contact
  url: https://www.alphabiopharma.com/en/contact/23.html
- type: Careers
  url: https://www.alphabiopharma.com/en/vocation/20.html
- type: Investors
  url: https://www.alphabiopharma.com/en/investment/27.html
- type: Publications
  url: https://www.alphabiopharma.com/en/innovation/38.html
- type: Research
  url: https://www.alphabiopharma.com/en/development/31.html
- type: Products
  url: https://www.alphabiopharma.com/en/medicine1/32.html
- type: TherapeuticAreas
  url: https://www.alphabiopharma.com/en/ta/7.html
- type: CorporateSocialResponsibility
  url: https://www.alphabiopharma.com/en/society/29.html
- type: WellKnown
  url: well-known/alphabiopharma-well-known.yml
- type: Packages
  url: packages/alphabiopharma-packages.yml
- type: LLMsTxt
  url: llms/alphabiopharma-llms.txt
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/alphabiopharma"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/alphabiopharma/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/alphabiopharma/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.